Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis (Journal of Clinical Investigation (2008) 118, (79-88) DOI: 10.1172/JCI33700);Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis

Journal of Clinical Investigation

Volumn 118, Issue 1, 2008, Pages 79-88

  Maclean, Kirsteen H ^a   Dorsey, Frank C ^b   Cleveland, John L ^b   Kastan, Michael B ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; ATM PROTEIN; CASPASE; CHLOROQUINE; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATAXIA TELANGIECTASIA; AUTOPHAGY; B LYMPHOCYTE; BURKITT LYMPHOMA; CANCER CELL; CANCER PREVENTION; CARCINOGENESIS; CELL DEATH; CELL STRESS; COLORECTAL CANCER; CONTROLLED STUDY; DRUG TARGETING; FEMALE; FIBROBLAST; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN CELL; LYSOSOME; MALE; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN DEGRADATION; TRANSGENIC MOUSE;

EID: 38149141767     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI33700C1     Document Type: Erratum

References (59)

1. Lowe, S.W., and Sherr, C.J. 2003. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Genet. Dev. 13:77-83.
2. Eischen, C.M., Weber, J.D., Roussel, M.F., Sherr, C.J., and Cleveland, J.L. 1999. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 13:2658-2669.
3. Schmitt, C.A., McCurrach, M.E., de Stanchina, E., Wallace-Brodeur, R.R., and Lowe, S.W. 1999. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev. 13:2670-2677.
4. Giaccia, A.J., and Kastan, M.B. 1998. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12:2973-2983.
5. Kastan, M.B., and Bartek, J. 2004. Cell-cycle checkpoints and cancer. Nature. 432:316-323.
6. Siliciano, J.D., et al. 1997. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11:3471-3481.
7. Canman, C.E., et al. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 281:1677-1679.
8. Tibbetts, R.S., et al. 1999. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13:152-157.
9. Pusapati, R.V., et al. 2006. ATM promotes apoptosis and suppresses tumorigenesis in response to Myc. Proc. Natl. Acad. Sci. U. S. A. 103:1446-1451.
10. Shreeram, S., et al. 2006. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase. J. Exp. Med. 203:2793-2799.
11. Maclean, K.H., Kastan, M.B., and Cleveland, J.L. 2007. Atm deficiency affects both apoptosis and proliferation to augment myc-induced lymphomagenesis. Mol. Cancer Res. 5:705-711.
12. Bakkenist, C.J., and Kastan, M.B. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 421:499-506.
13. Kitagawa, R., Bakkenist, C.J., McKinnon, P.J., and Kastan, M.B. 2004. Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev. 18:1423-1438.
14. Langdon, W.Y., Harris, A.W., Cory, S., and Adams, J.M. 1986. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell. 47:11-18.
15. Nilsson, J.A., et al. 2005. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation. Cancer Cell. 7:433-444.
16. Littlewood, T.D., Hancock, D.C., Danielian, P.S., Parker, M.G., and Evan, G.I. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686-1690.
17. Zindy, F., et al. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:2424-2433.
18. Maclean, K.H., et al. 2003. c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-X(L). Mol. Cell. Biol. 23:7256-7270.
19. Barlow, C., et al. 1996. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 86:159-171.
20. Harvey, M., McArthur, M.J., Montgomery, C.A., Jr., Bradley, A., and Donehower, L.A. 1993. Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J. 7:938-943.
21. Boya, P., et al. 2005. Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol. 25:1025-1040.
22. Amaravadi, R.K., et al. 2007. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. 117:326-336.
23. Juin, P., Hueber, A.O., Littlewood, T., and Evan, G. 1999. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 13:1367-1381.
24. Askew, D.S., Ashmun, R.A., Simmons, B.C., and Cleveland, J.L. 1991. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene. 6:1915-1922.
25. Evan, G.I., et al. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:119-128.
26. Fanidi, A., Harrington, E.A., and Evan, G.I. 1992. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Proc. Natl. Acad. Sci. U. S. A. 59:554-556.
27. Bissonnette, R.P., Echeverri, F., Mahboubi, A., and Green, D.R. 1992. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature. 359:552-554.
28. Lindsten, T., et al. 2000. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol. Cell. 6:1389-1399.
29. Levine, B., and Klionsky, D.J. 2004. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell. 6:463-477.
30. Ferraro, E., and Cecconi, F. 2007. Autophagic and apoptotic response to stress signals in mammalian cells. Arch. Biochem. Biophys. 462:210-219.
31. Zaidi, A.U., et al. 2001. Chloroquine-induced neuronal cell death is p53 and Bcl-2 family-dependent but caspase-independent. J. Neuropathol. Exp. Neurol. 60:937-945.
32. Carew, J.S., et al. 2007. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood. 110:313-322.
33. Paludan, C., et al. 2005. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science. 307:593-596.
34. Shacka, J.J., et al. 2006. Bafilomycin A1 inhibits chloroquine-induced death of cerebellar granule neurons. Mol. Pharmacol. 69:1125-1136.
35. Komatsu, M., et al. 2005. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 169:425-434.
36. Kabeya, Y., et al. 2000. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19:5720-5728.
37. Mizushima, N., et al. 2001. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J. Cell Biol. 152:657-668.
38. Pankiv, S., et al. 2007. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282:24131-24145.
39. Bjorkoy, G., et al. 2005. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J. Cell Biol. 171:603-614.
40. Stoka, V., Turk, V., and Turk, B. 2007. Lysosomal cysteine cathepsins: signaling pathways in apoptosis. Biol. Chem. 388:555-560.
41. Seglen, P.O., and Gordon, P.B. 1982. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 79:1889-1892.
42. Petiot, A., Ogier-Denis, E., Blommaart, E.F., Meijer, A.J., and Codogno, P. 2000. Distinct classes of phosphatidylinositol 3′-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J. Biol. Chem. 275:992-998.
43. Bartek, J., and Lukas, J. 2007. DNA damage checkpoints: from initiation to recovery or adaptation. Curr. Opin. Cell Biol. 19:238-245.
44. Adams, J.M., et al. 1985. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318:533-538.
45. Geser, A., Brubaker, G., and Draper, C.C. 1989. Effect of a malaria suppression program on the incidence of African Burkitt's lymphoma. Am. J. Epidemiol. 129:740-752.
46. Ohsumi, Y. 2001. Molecular dissection of autophagy: two ubiquitin-like systems. Nat. Rev. Mol. Cell Biol. 2:211-216.
47. Poole, B., and Ohkuma, S. 1981. Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J. Cell Biol. 90:665-669.
48. Glaumann, H., and Ahlberg, J. 1987. Comparison of different autophagic vacuoles with regard to ultrastructure, enzymatic composition, and degradation capacity - formation of crinosomes. Exp. Mol. Pathol. 47:346-362.
49. Wei, M.C., et al. 2001. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 292:727-730.
50. Boya, P., et al. 2003. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene. 22:3927-3936.
51. Vaux, D.L., Cory, S., and Adams, J.M. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:440-442.
52. Feng, Z., Zhang, H., Levine, A.J., and Jin, S. 2005. The coordinate regulation of the p53 and mTOR pathways in cells. Proc. Natl. Acad. Sci. U. S. A. 102:8204-8209.
53. Crighton, D., et al. 2006. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell. 126:121-134.
54. Colell, A., et al. 2007. GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell. 129:983-997.
55. Shiloh, Y., and Kastan, M.B. 2001. ATM: genome stability, neuronal development, and cancer cross paths. Adv. Cancer Res. 83:209-254.
56. Kundu, M., and Thompson, C.B. 2005. Macroautophagy versus mitochondrial autophagy: a question of fate? Cell Death Differ. 12(Suppl. 2):1484-1489.
57. Kondo, Y., Kanzawa, T., Sawaya, R., and Kondo, S. 2005. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer. 5:726-734.
58. Williams-Simons, L., and Westphal, H. 1999. EIIaCre - utility of a general deleter strain. Transgenic Res. 8:53-54.
59. Eischen, C.M., Woo, D., Roussel, M.F., and Cleveland, J.L. 2001. Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis. Mol. Cell. Biol. 21:5063-5070.